Supernus Pharmaceuticals (SUPN)
NASDAQ:SUPN
Holding SUPN?
Track your performance easily

Supernus Pharmaceuticals (SUPN) Financial Statements

476 Followers

Supernus Pharmaceuticals Financial Overview

Supernus Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $0.088; its P/E ratio is 348.24; Supernus Pharmaceuticals is scheduled to report earnings on November 5, 2024, and the estimated EPS forecast is $0.44. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 168.32M$ 143.64M$ 153.88M$ 135.56M$ 153.76M
Gross Profit$ 150.41M$ 127.33M$ 134.28M$ 114.47M$ 130.30M
EBIT$ 26.30M$ 243.00K$ 9.89M$ -16.22M$ 10.52M
EBITDA$ 47.02M$ 20.99M$ 31.78M$ 4.51M$ 31.62M
Net Income Common Stockholders$ 19.92M$ 124.00K$ -15.98M$ -831.00K$ 16.95M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 347.19M$ 297.74M$ 200.19M$ 151.66M$ 58.44M
Total Assets$ 1.32B$ 1.30B$ 1.29B$ 1.29B$ 1.79B
Total Debt$ 30.29M$ 32.99M$ 33.84M$ 34.18M$ 741.66M
Net Debt$ -316.89M$ -264.74M$ -166.35M$ -117.48M$ 683.22M
Total Liabilities$ 358.38M$ 374.92M$ 372.97M$ 373.19M$ 879.66M
Stockholders Equity$ 957.45M$ 929.17M$ 912.19M$ 919.91M$ 912.15M
Cash Flow-
Free Cash Flow$ 35.56M$ 38.15M$ 35.73M$ -19.82M$ 50.46M
Operating Cash Flow$ 35.62M$ 38.40M$ 35.88M$ -19.66M$ 50.74M
Investing Cash Flow$ -48.59M$ -51.62M$ 34.63M$ 61.09M$ 238.13M
Financing Cash Flow$ 1.66M$ 1.57M$ -230.00K$ -478.92M$ 80.17M
Currency in USD

Supernus Pharmaceuticals Earnings and Revenue History

Supernus Pharmaceuticals Debt to Assets

Supernus Pharmaceuticals Cash Flow

Supernus Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis